Cost-utility analysis of aprepitant for patients who truly need it in a Japanese health care setting.

被引：0
|
作者：
Tsukiyama, Ikuto
Ando, Masahiko
Tsukiyama, Sumiyo
Takeuchi, Masayuki
Ejiri, Masayuki
Yamamoto, Yoshihiro
Asai, Nobuhiro
Saito, Hiroko
Arakawa, Ichiro
Inoue, Tadao
Matsuura, Katsuhiko
Kubo, Akihito
机构：
[1] Aichi Med Univ Hosp, Dept Pharm, Nagakute, Aichi, Japan
[2] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan
[3] Aichi Med Univ, Div Resp Med & Allergol, Sch Med, Aichi, Japan
[4] Meijo Univ, Fac Pharm, Nagoya, Aichi, Japan
[5] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan
[6] Ohu Univ, Sch Pharmaceut Sci, Fukushima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18243
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Cost-utility analysis of palliative care in patients with advanced cancer: a retrospective study
    Hao Wu
    Ping Lin
    Shujuan Yang
    Wei Zhang
    Wenjuan Tao
    BMC Palliative Care, 20
  • [22] Cost-Utility Estimations of Palliative Care in Patients With Pancreatic Adenocarcinoma: A Retrospective Analysis
    Ljungman, David
    Hyltander, Anders
    Lundholm, Kent
    WORLD JOURNAL OF SURGERY, 2013, 37 (08) : 1883 - 1891
  • [23] Cost-utility analysis of palliative care in patients with advanced cancer: a retrospective study
    Wu, Hao
    Lin, Ping
    Yang, Shujuan
    Zhang, Wei
    Tao, Wenjuan
    BMC PALLIATIVE CARE, 2021, 20 (01)
  • [24] A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib
    Jewitt, K.
    Pilgrim, H.
    Ward, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 38 - 38
  • [25] Cost-utility analysis of great saphenous vein ablation with radiofrequency, foam and surgery in the emerging health-care setting of Thailand
    Siribumrungwong, Boonying
    Noorit, Pinit
    Wilasrusmee, Chumpon
    Leelahavarong, Pattara
    Thakkinstian, Ammarin
    Teerawattananon, Yot
    PHLEBOLOGY, 2016, 31 (08) : 573 - 581
  • [26] ECONOMIC-EVALUATION AND HEALTH-CARE .4. COST-UTILITY ANALYSIS
    ROBINSON, R
    BRITISH MEDICAL JOURNAL, 1993, 307 (6908): : 859 - 862
  • [27] Cost-utility analysis of hepatitis A prevention among health-care workers in Israel
    Chodick, G
    Lerman, Y
    Wood, F
    Aloni, H
    Peled, T
    Ashkenazi, S
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 44 (02) : 109 - 115
  • [28] Reviewing the literature of cost-effectiveness and cost-utility analysis in health
    Sancho, Leyla Gomes
    CADERNOS DE SAUDE PUBLICA, 2008, 24 (12): : 2735 - 2746
  • [29] A Cost-Utility Analysis of Endovascular Thrombectomy in a Real-World Setting
    Koto, Prosper S.
    Hu, Sherry X.
    Virani, Karim
    Simpkin, Wendy L.
    Christian, Christine A.
    Cao, Huiling
    Shankar, Jai J. S.
    Phillips, Stephen J.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2020, 47 (01) : 50 - 60
  • [30] COST-UTILITY ANALYSIS OF APREMILAST FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN THE ITALIAN SETTING
    Capri, S.
    Barbieri, M.
    Oskar, B.
    VALUE IN HEALTH, 2015, 18 (07) : A646 - A646
12345